Medical technology company Senseonics Holdings Inc (NYSE American:SENS) announced on Tuesday that it has approved non-qualified stock options to 16 new non-executive employees under its 2019 Inducement Plan and NYSE American Company Guide Section 711(a).

On the grant date of 1 October 2019, the 16 new non-executive employees received non-qualified stock options to purchase an aggregate of 263,000 shares of the company's common stock under an inducement plan.

Subject to each employee's continued service with the company at the applicable vesting date, 25% of the shares underlying the options will vest on the first anniversary of the start date, with the remainder vesting in monthly installments over the subsequent three year period.

The company added that it continues to build its team as it works to bring its Eversense CGM System to more people with diabetes in the US.